|
Market Closed -
Euronext Paris
01:55:00 03/10/26 am AEST
|
5-day change | 1st Jan Change | ||
| 70.81 EUR | -3.13% |
|
-1.37% | -14.40% |
| 03/10 | European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading | MT |
| 02/10 | The Great Return of Bonds: Why Dividend Stocks Have Lost Their Superpower |
Company Valuation: Sanofi
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 111,194 | 112,665 | 112,549 | 116,968 | 100,655 | 84,835 | - | - |
| Change | - | 1.32% | -0.1% | 3.93% | -13.95% | -15.72% | - | - |
| Enterprise Value (EV) 1 | 121,177 | 119,102 | 120,342 | 125,740 | 111,663 | 96,743 | 93,448 | 90,051 |
| Change | - | -1.71% | 1.04% | 4.49% | -11.2% | -13.36% | -3.41% | -3.64% |
| P/E | 17.8x | 16.7x | 20.8x | 20.4x | 12.9x | 11.3x | 9.81x | 8.46x |
| PBR | 1.62x | 1.5x | 1.52x | 1.51x | 1.41x | 1.15x | 1.08x | 1.02x |
| PEG | - | 2.07x | -1.1x | 3.14x | 0.3x | -6.3x | 0.7x | 0.5x |
| Capitalization / Revenue | 2.94x | 2.62x | 2.61x | 2.85x | 2.31x | 1.78x | 1.68x | 1.6x |
| EV / Revenue | 3.21x | 2.77x | 2.79x | 3.06x | 2.56x | 2.03x | 1.85x | 1.69x |
| EV / EBITDA | 9.95x | 8.14x | 8.44x | 9.76x | 8.22x | 6.57x | 5.96x | 5.29x |
| EV / EBIT | 11.3x | 9.13x | 9.5x | 11.1x | 9.19x | 7.27x | 6.68x | 5.95x |
| EV / FCF | 15x | 14x | 14.2x | 21.1x | 13.8x | 11.6x | 10.4x | 8.95x |
| FCF Yield | 6.68% | 7.12% | 7.04% | 4.74% | 7.24% | 8.59% | 9.64% | 11.2% |
| Dividend per Share 2 | 3.33 | 3.56 | 3.76 | 3.92 | 4.12 | 4.255 | 4.499 | 4.798 |
| Rate of return | 3.76% | 3.96% | 4.19% | 4.18% | 4.98% | 6.01% | 6.35% | 6.78% |
| EPS 2 | 4.97 | 5.37 | 4.31 | 4.59 | 6.4 | 6.285 | 7.222 | 8.366 |
| Distribution rate | 67% | 66.3% | 87.2% | 85.4% | 64.4% | 67.7% | 62.3% | 57.4% |
| Net sales 1 | 37,761 | 42,997 | 43,070 | 41,081 | 43,626 | 47,662 | 50,623 | 53,132 |
| EBITDA 1 | 12,183 | 14,627 | 14,259 | 12,889 | 13,583 | 14,734 | 15,689 | 17,008 |
| EBIT 1 | 10,714 | 13,040 | 12,670 | 11,343 | 12,149 | 13,312 | 13,999 | 15,142 |
| Net income 1 | 6,223 | 6,720 | 5,400 | 5,744 | 7,813 | 7,484 | 8,904 | 10,330 |
| Net Debt 1 | 9,983 | 6,437 | 7,793 | 8,772 | 11,008 | 11,908 | 8,613 | 5,215 |
| Reference price 2 | 88.58 | 89.84 | 89.76 | 93.74 | 82.72 | 70.81 | 70.81 | 70.81 |
| Nbr of stocks (in thousands) | 1,255,293 | 1,254,060 | 1,253,891 | 1,247,793 | 1,216,810 | 1,198,069 | - | - |
| Announcement Date | 4/2/22 | 3/2/23 | 1/2/24 | 30/1/25 | 29/1/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 11.27x | 2.03x | 6.57x | 6.01% | 95.48B | ||
| 32.45x | 11.78x | 23.93x | 0.61% | 1,019B | ||
| 28.48x | 6.32x | 17.74x | 2.09% | 617B | ||
| 33.26x | 7.78x | 16.08x | 2.64% | 464B | ||
| 104.98x | 5.87x | 24.89x | 2.36% | 356B | ||
| 18.81x | 4.58x | 11.36x | 2.9% | 333B | ||
| 19.83x | 5.17x | 12.78x | 3.09% | 267B | ||
| 20.02x | 4.17x | 11.86x | 2.13% | 244B | ||
| 25.46x | 6.66x | 11.86x | 2.5% | 218B | ||
| -43.78x | 6.39x | 24.97x | 2.27% | 179B | ||
| Average | 25.08x | 6.08x | 16.21x | 2.66% | 379.27B | |
| Weighted average by Cap. | 31.29x | 7.47x | 18.31x | 2.06% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SAN Stock
- Valuation Sanofi
Select your edition
All financial news and data tailored to specific country editions
















